- ►nih.gov A Eckstein, B Quadbeck, G Mueller, AW … - British Journal of Ophthalmology, 2003 - bjo.bmj.com Results: There was no difference in the clinical manifestations of TAO between
smokers and non-smokers at the beginning of treatment. However, CAS decreased
(p<0.05) and motility improved (p<0.02) significantly faster and to a ... Cited by 54 - Related articles - BL Direct - All 9 versions
- ►annals.org L Bartalena, C Marcocci, ML Tanda, L Manetti, … - Annals of Internal Medicine, 1998 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: It is unclear whether smoking affects the course of Graves ... Cited by 128 - Related articles - BL Direct - All 5 versions
J Pfeilschifter, R Ziegler - Clinical Endocrinology, 1996 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 80 - Related articles - BL Direct - All 4 versions
MF Prummel, WM Wiersinga, MP Mounts, L … - Archives of Internal Medicine, 1990 - archinte.highwire.org \s=b\Many clinicians have the impression that treatment of thy- roid dysfunction
ameliorates ophthalmopathy in Graves' dis- ease. The aim of our study was to
relate thyroid function to the severity of Graves' ophthalmopathy. We ... Cited by 87 - Related articles - All 3 versions
- ►eje.org GE Krassas, W Wiersinga - European Journal of Endocrinology, 2006 - eje.org New studies have shown that smoking may protect against the development of
thyroid peroxidase antibodies, which may result in a decreased risk of
Hashimoto's hypothyroidism (HH), whereas it stimulates the development of ... Cited by 24 - Related articles - BL Direct - All 7 versions
- ►eje.org GE Krassas, M Segni, WM Wiersinga - European Journal of Endocrinology, 2005 - eje.org Results: Out of 1963 patients with juvenile Graves' hyperthyroidism seen by
respondents in the last 10 years, 641 (33%) had GO; about one-third of GO cases
were 10 years old, and two-thirds were 11–18 years old. The prevalences ... Cited by 26 - Related articles - BL Direct - All 7 versions
C Marcocci, G Bruno-Bossio, L Manetti, ML … - CLINICAL ENDOCRINOLOGY-OXFORD-, 1999 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 59 - Related articles - BL Direct - All 3 versions
WM Wiersinga, L Bartalena - Thyroid, 2002 - liebertonline.com Graves' ophthalmopathy is clinically relevant in approximately 50% of patients
with Graves' disease, severe forms affecting 3%–5% of patients. Two age peaks
of incidence are observed in the fifth and seventh decades of life, with ... Cited by 91 - Related articles - BL Direct - All 5 versions
L Bartalena, E Martino, C Marcocci, F Bogazzi, … - Journal of endocrinological investigation(Testo …, 1989 - cat.inist.fr More on smoking habits and Graves' ophthalmopathy. L BARTALENA, E MARTINO,
C MARCOCCI, F BOGAZZI, M PANICUCCI, F VELLUZZI, A LOVISELLI ... Cited by 114 - Related articles - All 2 versions
